Status:

COMPLETED

Retrospective Health Care Utilisation and Current Quality of Life in Adults With Chronic Otitis Media Who Had a Middle Ear Surgery

Lead Sponsor:

Cochlear

Collaborating Sponsors:

QbD Clinical

Suministros Hospitalarios Medical Group

Conditions:

Chronic Otitis Media

Eligibility:

All Genders

18+ years

Brief Summary

The objective of this multicentre study is to evaluate the standard of care of participants diagnosed with Chronic Otitis Media that have already gone through a first middle ear surgery but still have...

Eligibility Criteria

Inclusion

  • Adult subjects, 18 years or older.
  • Subjects with conductive or mixed hearing loss.
  • Subjects with historically documented diagnosis of Chronic Otitis Media (COM) with or without cholesteatoma in the operated ear.
  • Subjects who have undergone primary tympanoplasty type I-V to improve hearing between 2010-2016.
  • Subjects with a Pure Tone Average (PTA)4 air-bone gap ≥30 decibels (dB) OR PTA4 air-bone gap between 25-30 dB with an air conduction threshold PTA4 ≥40 dB HL within 12 months after primary tympanoplasty in the operated ear.
  • Subjects who have been recommended by their health care professional to try a hearing aid to improve hearing in the operated ear.
  • Pre-op audiogram, maximum 1 year prior to the primary tympanoplasty, and post-op audiogram for the primary tympanoplasty are available.
  • Aided audiogram, unaided if no hearing device is used, available between 2018 and the point of enrolment.
  • Subjects are fluent in the language used for study questionnaires: German, French, Spanish.
  • Subjects are willing and able to provide written informed consent. For France: subjects do not oppose to participate in the study.
  • Medical Record data is available throughout the defined data search period, from primary tympanoplasty to point of enrolment.

Exclusion

  • Subjects are unable or unwilling to comply with the requirements of the study as determined by the investigator.
  • Investigator site personnel directly affiliated with this study and/or their immediate families; immediate family is defined as a spouse, parent, child, or sibling.
  • Cochlear employees or employees of Contract Research Organizations or contractors engaged by Cochlear for the purposes of this study.
  • For France only:
  • Subjects who are not affiliated to social security.
  • Subjects who are under legal protection.

Key Trial Info

Start Date :

February 1 2022

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

October 9 2023

Estimated Enrollment :

69 Patients enrolled

Trial Details

Trial ID

NCT04864912

Start Date

February 1 2022

End Date

October 9 2023

Last Update

March 7 2025

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

Hôpital Bicêtre, Hôpitaux universitaires Paris Sud AP-HP

Le Kremlin-Bicêtre, France, 94275

2

ENT department - Bâtiment Pierre Paul Riquet - Hôpital Purpan

Toulouse, France, 31059

3

Universitätsklinik für Hals-, Nasen und Ohrenheilkunde

Freiburg im Breisgau, Germany, 79106

4

Hals-, Nasen- und Ohrenklinik, Universitätsklinikum Heidelberg

Heidelberg, Germany, 69120